Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Short term Debt (2016 - 2025)

Fresenius Medical Care AG has reported Short term Debt over the past 17 years, most recently at $1.9 billion for Q4 2025.

  • Quarterly results put Short term Debt at $1.9 billion for Q4 2025, up 203.25% from a year ago — trailing twelve months through Dec 2025 was $1.9 billion (up 203.25% YoY), and the annual figure for FY2025 was $1.9 billion, up 203.25%.
  • Short term Debt for Q4 2025 was $1.9 billion at Fresenius Medical Care AG, up from $614.7 million in the prior quarter.
  • Over the last five years, Short term Debt for FMCQF hit a ceiling of $1.9 billion in Q4 2025 and a floor of $524.7 million in Q4 2023.
  • Median Short term Debt over the past 5 years was $708.1 million (2022), compared with a mean of $895.2 million.
  • Biggest five-year swings in Short term Debt: tumbled 36.44% in 2021 and later skyrocketed 203.25% in 2025.
  • Fresenius Medical Care AG's Short term Debt stood at $764.1 million in 2021, then dropped by 7.33% to $708.1 million in 2022, then decreased by 25.9% to $524.7 million in 2023, then increased by 17.15% to $614.7 million in 2024, then skyrocketed by 203.25% to $1.9 billion in 2025.
  • The last three reported values for Short term Debt were $1.9 billion (Q4 2025), $614.7 million (Q4 2024), and $524.7 million (Q4 2023) per Business Quant data.